Letter to the Editor

Page 6

Recently published articles about Letter to the Editor

PCC
Letter to the Editor

March 3, 2024

Notice of retraction for a letter to the editor.
PCC
Drug Interactions Between Psychotropic Medications and Mpox Treatment
Letter to the Editor

February 15, 2024

The authors review pharmacologic interactions of Mpox treatments with psychotropic medications and antidepressants, antipsychotics, mood stabilizers, and sedatives.
, , , et al
PCC
Intravenous Ketamine vs Intranasal Esketamine for TRD
Letter to the Editor

February 13, 2024

Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketamine for treatment-resistant depression.
, , , et al
PCC
Fentanyl-Laced Marijuana Use in Adolescents [Retracted]
Letter to the Editor

February 6, 2024

, , , et al
JCP
Reckoning Risk Retrospectively: Reply to Taipale et al
Letter to the Editor

January 22, 2024

In a reply to Taipale and colleagues, Dr Andrade discusses estimation of risk in case-control studies and in RCTs.
JCP
Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use
Letter to the Editor

January 22, 2024

The authors provide additional relative risk data in response to Dr Andrade’s comments on their study.
, , , et al
JCP
Testing for Sleep-Disordered Breathing in Psychiatric Practice
Letter to the Editor

January 10, 2024

Dr Barry Krakow comments on Benca and colleagues’ recent review of sleep apnea in psychiatric practice and calls for clinicians to screen for sleep-disordered breathing at intake.
PCC
Deprescribing Benzodiazepines: Is Harm Reduction Enough?
Letter to the Editor

December 28, 2023

Vania Modesto-Lowe, MD, MPH, and Claire N. Aurilio, BS, comment on a recent publication in the PCC.
,
PCC
Commentary on Catatonia and Competency to Stand Trial
Letter to the Editor

December 26, 2023

N. A. Uvais, MBBS, DPM, comments on a recent publication in the PCC.
PCC
Psychotropic-Related Sexual Dysfunction: Clinical Insights
Letter to the Editor

December 21, 2023

Clinicians should be cognizant of and avidly screen for psychotropic-related sexual dysfunction during routine follow-up clinic visits.
PCC
Insights Into Poststroke Depression
Letter to the Editor

August 31, 2023

The authors shed light on risk factors, purported mechanisms, diagnostic tips, and treatment options for poststroke depression.
,
PCC
Comment on the Midlevel Care Provider System in New York State
Letter to the Editor

August 24, 2023

This letter explores a provider type that is part of the solution to the psychiatric shortage: psychiatric pharmacists.
, ,

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe